Mylin Biotech has emerged and evolved as a "research and innovations" based young organisation since its humble beginnings in the year 2012.
The products at Mylin Biotech undergo stringent clinical trials right from Phase II, III, IV to ensure their efficacy and adherence to world class quality standards.
We are proud to have completed and published 5 clinical trials in reputed journals of Pre-dialysis, Dialysis, Cancer and Liver cirrhosis.
The relentless efforts of the Mylin R&D team has helped in the filing of 3 patent applications in India and 1 PCT.
Relentless pursuit of the “diseases that begin in the gut” and overcome them by providing targeted interventional therapies, reduce the disease burden and enhance the quality of patient's life.
To emerge as the leaders in providing Evidence based therapeutic solutions that are both, beneficial and affordable to all patients across India and the rest of the world.